Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer.
Rugo H; Shtivelman E; Perez A; Vogel C; Franco S; Tan Chiu E; Melisko M; Tagliaferri M; Cohen I; Shoemaker M; Tran Z; Tripathy D; Breast Cancer Research And Treatment, 2007, vol. 105, issue 1, p 17, ISSN 01676806. ISBN 01676806.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef